QURE
(NASDAQ)uniQure N.V.
$39.43-- (--)
Loading... - Market loading
uniQure (QURE) Stock Price & Financial Analysis
uniQure Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$38.86 - $40.50
52-Week High$71.50
52-Week Low$8.73
Open$39.90
Volume834.33K
Average Volume (3M)2.39M
Market Cap2.47B
Shares Outstanding62.74M
Price to Sales (P/S)136.74
Price to Book (P/B)16.57
EV/EBITDA-15.84
Revenue (TTM)18.09M
Net Income (TTM)-208.87M
Free Cash Flow (TTM)-172.12M
EPS (TTM)$-3.58
Profit Margin-1154.42%
Operating Margin-1048.94%
Return on Equity (ROE)-139.86%
Debt to Equity0.42
50-Day MA$35.17
200-Day MA$29.13
52-Week Change156.37%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$38.86 - $40.50
52-Week High$71.50
52-Week Low$8.73
Open$39.90
Volume834.33K
Average Volume (3M)2.39M
Market Cap2.47B
Shares Outstanding62.74M
Price to Sales (P/S)136.74
Price to Book (P/B)16.57
EV/EBITDA-15.84
Revenue (TTM)18.09M
Net Income (TTM)-208.87M
Free Cash Flow (TTM)-172.12M
EPS (TTM)$-3.58
Profit Margin-1154.42%
Operating Margin-1048.94%
Return on Equity (ROE)-139.86%
Debt to Equity0.42
50-Day MA$35.17
200-Day MA$29.13
52-Week Change156.37%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About uniQure
What is the current stock price for QURE?
As of the latest trading session, QURE stock trades at $39.43. The 52-week range is $8.73–$71.50, with a day range of $38.86–$40.50.
What is the P/E ratio for QURE?
The P/E ratio (Price-to-Earnings) for QURE is shown in the Key Statistics section. This valuation metric helps compare uniQure N.V. to industry peers.
Does QURE pay dividends?
uniQure does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for QURE?
Based on 12 analysts, the consensus for QURE is Buy.
What is the market cap of QURE?
uniQure's market capitalization is $2.47B, classifying it as a mid-cap company. uniQure operates in the Healthcare sector within the Biotechnology industry.